ADVB

Advanced Biomed Inc. Common Stock

There isn't enough reported data to score ADVB yet.

ADVB Fundamentals

MetricStatus
Unavailable
Healthy
Unavailable
Strong

ADVB's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.

ADVB PE Valuation

ADVB has no meaningful PE right now: it lost money over the past year.

ADVB Forward outlook

There aren't enough analyst estimates for ADVB to show an outlook.

ADVB Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $3.31 on Nov 12.

There is not enough scenario data to assess ADVB's risk to reward.

ADVB Earnings Per Share

Q4 2023: $-3.20Q1 2024: $-3.60Q2 2024: $-2.78Q3 2025: $-3.29Q4 2025: $3.71Q1 2026: $4.73
Q4 2023: $-3.20Q1 2024: $-3.60Q2 2024: $-2.78Q3 2025: $-3.29Q4 2025: $3.71Q1 2026: $4.73
QuarterTTM EPSYoY
Q2 2024-$2.78+$1.02
Q1 2024-$3.60+$2.40

ADVB has returned to profit: it earned $4.73 per share over the past year, after losing money the year before.

ADVB Quarterly Revenue

Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

ADVB's revenue is shrinking: $0 last quarter.

ADVB Free Cash Flow

Q4 2023: โˆ’$13,269Q1 2024: โˆ’$1MQ2 2024: โˆ’$529,084Q3 2024: โˆ’$49,658Q4 2024: --Q1 2025: โˆ’$3MQ2 2025: โˆ’$2MQ3 2025: โˆ’$612,113Q4 2025: โˆ’$526,464Q1 2026: โˆ’$241,039Q2 2026: โˆ’$583,268Q3 2026: โˆ’$171,464
Q4 2023: โˆ’$13,269Q1 2024: โˆ’$1MQ2 2024: โˆ’$529,084Q3 2024: โˆ’$49,658Q4 2024: --Q1 2025: โˆ’$3MQ2 2025: โˆ’$2MQ3 2025: โˆ’$612,113Q4 2025: โˆ’$526,464Q1 2026: โˆ’$241,039Q2 2026: โˆ’$583,268Q3 2026: โˆ’$171,464
QuarterFree cash flowYoY
Q3 2026-$171.5K+$440.6K
Q2 2026-$583.3K+$980.8K
Q1 2026-$241K+$3.2M
Q3 2025-$612.1K-$562.5K
Q2 2025-$1.6M-$1M
Q1 2025-$3.4M-$2.4M
Q3 2024-$49.7K+$569.5K
Q2 2024-$529.1K-$492.3K

ADVB has burned cash in almost every quarter: โˆ’$2M over the past year, against โˆ’$6M the year before.

ADVB Total Shares

Q4 2023: 1MQ1 2024: 1MQ2 2024: 1MQ4 2024: 1MQ1 2025: 1MQ2 2025: 1MQ3 2025: 1MQ4 2025: 1MQ1 2026: 1MQ3 2026: 2M
Q4 2023: 1MQ1 2024: 1MQ2 2024: 1MQ4 2024: 1MQ1 2025: 1MQ2 2025: 1MQ3 2025: 1MQ4 2025: 1MQ1 2026: 1MQ3 2026: 2M
PeriodChange %Net change
Quarterly+29%+367K shares
1 year+61%+626K shares
3 years+65%+652K shares

ADVB has 2M diluted shares, up 61% from a year ago.

ADVB Net Leverage

Q4 2025: -0.6xQ1 2026: -0.5x
Q4 2025: -0.6xQ1 2026: -0.5x
QuarterNet LeverageStatus
Q1 2026-0.5xNet Cash
Q4 2025-0.6xNet Cash

ADVB has more cash than debt.

ADVB Weekly Momentum

MetricValueStatus
RSI43.4Neutral
Stochastic6.3Oversold

ADVB's weekly RSI is 43 (neutral) and its Stochastic is 6 (oversold).

ADVB PE vs Healthcare Sector

MetricADVBSector medianRelative
PE1.1x26x96% below
PE %357439 pts below

ADVB has no meaningful PE right now: it lost money over the past year.

ADVB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$4.1420% below
20 week MA$6.6350% below
50 week MA$5.9044% below

ADVB is in a downtrend: it's below all three of its weekly moving averages, and 44% below its 50-week average.

ADVB Yearly ROI

YearStart priceEnd priceROI
2025$73.0$7.33-90%
2026 YTD$7.33$3.31-55%

ADVB has finished every year since 2025 lower, and it's down 55% so far in 2026.

Give your agent the market.

Get API key